Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 47 Neoplasms 10 Prostatic Neoplasms 8 Unspecified Adult Solid Tumor, Protocol Specific 6 Neoplasm Metastasis 6 Carcinoma, Ovarian Epithelial 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms, Male 5 Sarcoma 4 Ovarian Neoplasms 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Lung Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Kidney Neoplasms 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Burkitt Lymphoma 3 Wilms Tumor 2 Testicular Neoplasms 2 Teratoma 2

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × ixabepilone × Clear all

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡